Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 17 de 17
Filter
1.
Nature ; 627(8002): 38, 2024 Mar.
Article in English | MEDLINE | ID: mdl-38443636
3.
Kidney Blood Press Res ; 48(1): 545-555, 2023.
Article in English | MEDLINE | ID: mdl-37517398

ABSTRACT

INTRODUCTION: The evidence about the optimal revascularization strategy in patients with left main coronary artery (LMCA) disease and impaired renal function is limited. Thus, we aimed to compare the outcomes of LMCA disease revascularization (percutaneous coronary intervention [PCI] vs. coronary artery bypass grafting [CABG]) in patients with and without impaired renal function. METHODS: This retrospective cohort study included 2,138 patients recruited from 14 centers between 2015 and 2,019. We compared patients with impaired renal function who had PCI (n= 316) to those who had CABG (n = 121) and compared patients with normal renal function who had PCI (n = 906) to those who had CABG (n = 795). The study outcomes were in-hospital and follow-up major adverse cardiovascular and cerebrovascular events (MACCE). RESULTS: Multivariable logistic regression analysis showed that the risk of in-hospital MACCE was significantly higher in CABG compared to PCI in patients with impaired renal function (odds ratio [OR]: 8.13 [95% CI: 4.19-15.76], p < 0.001) and normal renal function (OR: 2.59 [95% CI: 1.79-3.73]; p < 0.001). There were no differences in follow-up MACCE between CABG and PCI in patients with impaired renal function (HR: 1.14 [95% CI: 0.71-1.81], p = 0.585) and normal renal function (HR: 1.12 [0.90-1.39], p = 0.312). CONCLUSIONS: PCI could have an advantage over CABG in revascularization of LMCA disease in patients with impaired renal function regarding in-hospital MACCE. The follow-up MACCE was comparable between PCI and CABG in patients with impaired and normal renal function.


Subject(s)
Coronary Artery Disease , Percutaneous Coronary Intervention , Humans , Percutaneous Coronary Intervention/adverse effects , Retrospective Studies , Treatment Outcome , Coronary Artery Bypass/adverse effects , Coronary Artery Disease/complications , Coronary Artery Disease/surgery , Kidney/surgery
5.
Crit Pathw Cardiol ; 20(1): 36-43, 2021 03 01.
Article in English | MEDLINE | ID: mdl-32657974

ABSTRACT

BACKGROUND: Atherosclerotic coronary plaque dissection (ACPD) is one cause of acute coronary syndrome (ACS) caused by underlying atherosclerosis. Spontaneous coronary artery dissection (SCAD) occurs outside the setting of atherosclerosis among young women and individuals with few or no conventional atherosclerotic risk factors, and has emerged as an important cause of ACS, and sudden death. A comparison between ACPD and SCAD has not been previously addressed in the literature. Our study will compare ACPD and SCAD. METHODS: Patients with confirmed diagnosis of SCAD and ACPD were retrospectively identified from 30 centers in 4 Arab Gulf countries between January 2011 and December 2017. In-hospital (ventricular tachycardia/ventricular fibrillation, myocardial infarction (MI), percutaneous coronary intervention, dissection extension, cardiogenic shock, death, implantable cardioverter-defibrillator placement) and follow-up (MI, de novo SCAD, spontaneous superior mesenteric artery dissection, death) events were compared between them. RESULTS: Eighty-three cases of SCAD and 48 ACPD were compared. ACPD patients were more frequently male (91.67% vs. 49.40%, P < 0.001) and older (58.5 vs. 44, P < 0.001). Cardiovascular risk factors were more prevalent in patients with ACPD, including diabetes mellitus (60.4% vs. 25.3%), dyslipidemia (62.5% vs. 38.5%), and hypertension (62.5% vs. 31.3%), P < 0.001. Hospital presentation of ST-elevation MI was diagnosed in 48% of SCAD versus 27% of ACPD patients (P = 0.012). SCAD patients received medical-only treatment in 40% of cases and ACPD in 21% (P = 0.042). In-hospital and follow-up events were comparable in both groups (P = 0.25). CONCLUSIONS: Despite a completely different pathophysiology of ACS between SCAD and ACPD, in-hospital and follow-up events were comparable.


Subject(s)
Coronary Vessel Anomalies , Coronary Angiography , Coronary Vessel Anomalies/complications , Coronary Vessel Anomalies/diagnosis , Coronary Vessel Anomalies/epidemiology , Dissection , Female , Humans , Male , Retrospective Studies
10.
J Electrocardiol ; 48(5): 783-90, 2015.
Article in English | MEDLINE | ID: mdl-26189887

ABSTRACT

BACKGROUND: Cardiac resynchronization therapy (CRT) reduces morbidity and mortality in selected patients with heart failure, but up to one third of patients may not respond to CRT. A transmural postero-lateral (TMPL) wall scar in the left ventricle (LV) or over the LV pacing site may attenuate clinical and echocardiographic response to CRT. METHODS AND RESULTS: We systematically searched PubMed, EMBASE, and Cochrane databases for studies examining the association between Cardiac magnetic resonance (CMR)-determined postero-lateral or LV pacing site scar and clinical and echocardiographic response to CRT. Eleven prospective studies were included. The presence of TMPL scar on pre-implant CMR was associated with a 75% lower chance of echocardiographic response to CRT, and a similarly lower chance of clinical response. Significant scar over LV pacing site on pre-implant CMR was also associated with a 46% lower chance of echocardiographic response to CRT, and a 67% lower chance of clinical response. CONCLUSIONS: The presence of transmural postero-lateral scar or significant scar within the LV pacing site detected by pre-implant CMR is associated with a lower rate of clinical or echocardiographic response to CRT.


Subject(s)
Cardiac Resynchronization Therapy/statistics & numerical data , Cicatrix/epidemiology , Cicatrix/pathology , Magnetic Resonance Imaging, Cine/statistics & numerical data , Myocardial Infarction/pathology , Myocardial Infarction/therapy , Aged , Cicatrix/therapy , Female , Humans , Male , Middle Aged , Myocardial Infarction/epidemiology , Prevalence , Prognosis , Reproducibility of Results , Risk Assessment , Sensitivity and Specificity , Treatment Outcome
11.
J Med Case Rep ; 9: 113, 2015 May 15.
Article in English | MEDLINE | ID: mdl-25975802

ABSTRACT

INTRODUCTION: Sinus arrest, atrio-ventricular block, supraventricular, and ventricular arrhythmias have been reported in patients with sleep apnea syndrome. The arrhythmias usually occur during sleep and contribute to the cardiovascular morbidity and mortality, and the treatment of sleep apnea usually results in the resolution of the brady- arrhythmias. Weight loss, continuous positive airway pressure (CPAP), oral appliances, and upper airway surgery are the recommended treatments, however, compliance and efficacy are issues. CASE PRESENTATION: A 58-year-old Arab man presented with recurrent presyncope. He was subsequently diagnosed with sleep apnea associated with frequent and significant sinus pauses. He presented a treatment challenge because he refused continuous positive airway pressure and pacemaker, however, he was successfully treated with theophylline. CONCLUSION: Frequent and significant sinus pause associated with sleep apnea was successfully treated with theophylline in our patient when the standard treatment of care was refused.


Subject(s)
Bradycardia/drug therapy , Sleep Apnea Syndromes/drug therapy , Bradycardia/etiology , Humans , Male , Middle Aged , Obesity/complications , Polysomnography , Sleep Apnea Syndromes/complications , Theophylline/therapeutic use , Treatment Refusal
12.
Disaster Med Public Health Prep ; 9(3): 319-28, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25869234

ABSTRACT

Space applications have evolved to play a significant role in disaster relief by providing services including remote sensing imagery for mitigation and disaster damage assessments; satellite communication to provide access to medical services; positioning, navigation, and timing services; and data sharing. Common issues identified in past disaster response and relief efforts include lack of communication, delayed ordering of actions (eg, evacuations), and low levels of preparedness by authorities during and after disasters. We briefly summarize the Space for Health (S4H) Team Project, which was prepared during the Space Studies Program 2014 within the International Space University. The S4H Project aimed to improve the way space assets and experiences are used in support of public health during disaster relief efforts. We recommend an integrated solution based on nano-satellites or a balloon communication system, mobile self-contained relief units, portable medical scanning devices, and micro-unmanned vehicles that could revolutionize disaster relief and disrupt different markets. The recommended new system of coordination and communication using space assets to support public health during disaster relief efforts is feasible. Nevertheless, further actions should be taken by governments and organizations in collaboration with the private sector to design, test, and implement this system.


Subject(s)
Disaster Planning/methods , Public Health Practice , Satellite Communications , Humans , Information Dissemination , Satellite Communications/economics
13.
Can Fam Physician ; 61(3): 256-62, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25767171

ABSTRACT

OBJECTIVE: To determine which screening tests family medicine residents order as part of preventive health care. DESIGN: A cross-sectional survey. SETTING: Alberta and Ontario. PARTICIPANTS: First- and second-year family medicine residents at the University of Alberta in Edmonton, the University of Calgary in Alberta, and McMaster University in Hamilton, Ont, during the 2011 to 2012 academic year. MAIN OUTCOME MEASURES: Demographic information, Likert scale ratings assessing ordering attitudes, and selections from a list of 38 possible tests that could be ordered for preventive health care for sample 38-year-old and 55-year-old female and male patients. Descriptive and comparative statistics were calculated. RESULTS: A total of 318 of 482 residents (66%) completed the survey. Recommended or appropriate tests were ordered by 82% (for cervical cytology) to 95% (for fasting glucose measurement) of residents. Across the different sample patients, residents ordered an average of 3.3 to 5.7 inappropriate tests per patient, with 58% to 92% ordering at least 1 inappropriate test per patient. The estimated average excess costs varied from $38.39 for the 38-year-old man to $106.46 for the 55-year-old woman. More regular use of a periodic health examination screening template did not improve ordering (P = .88). CONCLUSION: In general, residents ordered appropriate preventive health tests reasonably well but also ordered an average of 3.3 to 5.7 inappropriate tests for each patient. Training programs need to provide better education for trainees around inappropriate screening and work hard to establish good ordering behaviour in preparation for entering practice.


Subject(s)
Family Practice/methods , Internship and Residency , Mass Screening/statistics & numerical data , Practice Patterns, Physicians'/statistics & numerical data , Preventive Medicine/statistics & numerical data , Adult , Alberta , Attitude of Health Personnel , Cross-Sectional Studies , Family Practice/education , Female , Humans , Male , Middle Aged , Ontario , Surveys and Questionnaires
14.
J Am Coll Cardiol ; 61(23): 2383-7, 2013 Jun 11.
Article in English | MEDLINE | ID: mdl-23583244

ABSTRACT

OBJECTIVES: The aim of this study was to determine the availability of quinidine throughout the world. BACKGROUND: Quinidine is the only oral medication that is effective for preventing life-threatening ventricular arrhythmias due to Brugada syndrome and idiopathic ventricular fibrillation. However, because of its low price and restricted indication, this medication is not marketed in many countries. METHODS: We conducted a survey of the availability of quinidine by contacting professional medical societies and arrhythmia specialists worldwide. Physicians were e-mailed questionnaires requesting information concerning the quinidine preparation available at their hospital. We also requested information concerning cases of adverse arrhythmic events resulting from unavailability of quinidine. RESULTS: A total of 273 physicians from 131 countries provided information regarding the availability of quinidine. Quinidine was readily available in 19 countries (14%), not accessible in 99 countries (76%), and available only through specific regulatory processes that require 4 to 90 days for completion in 13 countries (10%). We were able to gather information concerning 22 patients who had serious arrhythmias probably related (10 cases) or possibility related (12 cases) to the absence of quinidine, including 2 fatalities possibly attributable to the unavailability of quinidine. CONCLUSIONS: The lack of accessibility of quinidine is a serious medical hazard at the global level.


Subject(s)
Brugada Syndrome/drug therapy , Global Health , Health Services Accessibility , Quinidine/supply & distribution , Quinidine/therapeutic use , Ventricular Fibrillation/drug therapy , Anti-Arrhythmia Agents/supply & distribution , Anti-Arrhythmia Agents/therapeutic use , Brugada Syndrome/complications , Brugada Syndrome/diagnosis , Cross-Sectional Studies , Drug Utilization , Female , Humans , Male , Needs Assessment , Risk Assessment , Surveys and Questionnaires , Survival Analysis , Ventricular Fibrillation/etiology , Ventricular Fibrillation/mortality
15.
Reprod Toxicol ; 25(1): 124-8, 2008 Jan.
Article in English | MEDLINE | ID: mdl-18077132

ABSTRACT

BACKGROUND: Isotretinoin is a known teratogen. Pregnancy prevention programs aimed at minimizing isotretinoin exposure in pregnancy have been implemented in North America with limited success. OBJECTIVE: To compare the management of fetal risk of isotretinoin in three countries, including information given to women, implementation of contraceptive methods, and pregnancy outcomes. METHODS: Pregnant women exposed to isotretinoin who called teratogen information services (TIS) in Israel, Italy and Canada between July 1998 and October 2006 were interviewed at the time of initial consultation and after the expected day of delivery. RESULTS: Fifty-three pregnant women exposed to isotretinoin contacted the TIS. Only 41% reported using a birth control method. Just one patient reported using two different forms. Forty-five percent of exposed pregnancies were terminated before delivery and 22% delivered healthy babies. Two babies were born with malformations. CONCLUSIONS: Since isotretinoin-exposed pregnancies still occur, there is a need for more effective strategies, which should take into account the cultural differences.


Subject(s)
Abnormalities, Drug-Induced/etiology , Abortion, Therapeutic , Contraception , Dermatologic Agents/toxicity , Drug Information Services , Fetus/drug effects , Isotretinoin/toxicity , Teratogens , Abnormalities, Drug-Induced/prevention & control , Adult , Canada , Female , Follow-Up Studies , Global Health , Guideline Adherence , Health Knowledge, Attitudes, Practice , Humans , Infant, Newborn , Israel , Italy , Live Birth , Patient Education as Topic , Practice Guidelines as Topic , Pregnancy , Pregnancy Trimester, First , Surveys and Questionnaires
17.
J Nutr Biochem ; 16(10): 587-93, 2005 Oct.
Article in English | MEDLINE | ID: mdl-16081276

ABSTRACT

A large pool of folate exists in the large intestine of humans. Preliminary evidence, primarily in vitro, suggests that this folate may be bioavailable. The purpose of this study was to test the hypothesis that supplemental folic acid and bacterially synthesized folate are absorbed across the large intestine of piglets. The pig was used as an animal model because it resembles the human in terms of folate absorption, at least in the small intestine. A tracer of [3H]-folic acid or [3H]-para-aminobenzoic acid ([3H]-PABA), a precursor of bacterially synthesized folate, was injected into the cecum of 11-day-old piglets. Feces and urine were collected for 3 days. Thereafter, piglets were killed, and livers and kidneys harvested. [3H]-Folate was isolated from biological samples by affinity chromatography using immobilized milk folate binding proteins and counted using a scintillation counter. In piglets injected with [3H]-folic acid, the feces, liver, urine and kidneys accounted for 82.1%, 12.3%, 3.9% and 1.7% of recovered [3H]-folate, respectively. In piglets injected with [3H]-PABA, the amount of recovered bacterially synthesized folate in the feces, liver and urine was 85.1%, 0.4% and 14.6%, respectively. Twenty-three percent and 13% of tritium were recovered in samples examined (liver, kidney, fecal and urine) from piglets injected with [3H]-folic acid and [3H]-PABA, respectively. Using our estimates of [3H]-folic acid absorption and the total and percent monoglutamyl folate content of piglet feces, we predict that at least 18% of the dietary folate requirement for the piglet could be met by folate absorption across the large intestine.


Subject(s)
Bacteria/metabolism , Folic Acid/biosynthesis , Folic Acid/metabolism , Intestinal Absorption , 4-Aminobenzoic Acid/administration & dosage , 4-Aminobenzoic Acid/metabolism , Animals , Animals, Newborn , Chromatography, Affinity , Diet , Feces/chemistry , Folic Acid/administration & dosage , Liver/chemistry , Male , Milk/chemistry , Swine , Tritium , Urine/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...